COMPARE · Data as of October 9, 2026

HSIC vs MCK

Verdict: Side-by-side breakdown using the Bull Rankings model. HSIC scored 52.7, MCK scored 74.2 — MCK leads.
Compare another set
HSIC
Henry Schein, Inc.
Medical Distribution · Quality-Growth
52.7
$84.01 · $9.4B
fundamentals as of
Score gap
21.5
MCK leads
MCK
McKesson Corporation
Medical Distribution · Quality-Growth
74.2
$938.84 · $109.5B
fundamentals as of
  • CheapestHSIC24.5x
  • Fastest growthMCK+12.4%
  • Highest qualityMCK81 / 100
  • Largest discount to fair valueHSIC-9%
THE BULL RANKINGS SCORECARD52.7/ 100 · BULL SCOREPEER MEDIANQUALITY62.6GROWTH61.3VALUE38.2
THE BULL RANKINGS SCORECARD74.2/ 100 · BULL SCOREPEER MEDIANQUALITY81.2GROWTH81.7VALUE61.6
HSICMCKQuality62.681.2Growth61.381.7Value38.261.6
cheap & fastrevenue growth →← cheaper (lower multiple)-4%22%19x30xHSICMCK

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFHSIC$569mMCK$6.1b
RevHSIC+6.5%MCK+12.4%
P/EHSIC24.5xMCK25.2x
PEGHSIC1.69MCK1.75
HSIC
stronger →← stronger
MCK
63
Qualityreturns · margins · balance sheet
81
61
Growthrevenue & earnings expansion
82
38
Valuevaluation vs sector peers
62
MCK is stronger on 3 of 3 pillars.
HSIC
MCK
$569mC+
FCF
$6.1bB+
+6.5%C+
Rev
+12.4%B+
0.81C+
D/E
Negative equity
24.5xB
P/E
25.2xB
1.69C+
PEG
1.75C+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
HSIC
MCK
9% below
Price vs fair valuelower is cheaper
1% below
~3%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~8%/yr
+5%
1-yr DCF upside
-10%
+9%
5-yr DCF upside
+1%
+15%
10-yr DCF upside
+18%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
HSIC
Why this score
  • Buying back stock
MCK
Why this score
  • Buying back stock
  • Raising its dividend
  • Durable high returns
HSICHenry Schein, Inc.
Medical Distribution · $84.01 · beta 0.84
Why now
Medical Distribution · market cap $9.4b. 9% off the 52-week high of $92.18. 15 sell-side analysts rate this a Buy with a mean 1-yr target of $97.27 (implying +16% upside).
Moat
ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 141% of net income — earnings translate cleanly into cash.
Risk
Net margin 3.0% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
MCKMcKesson Corporation
Medical Distribution · $938.84 · beta 0.30
Why now
Medical Distribution · market cap $109.5b. 6% off the 52-week high of $999.00. Revenue growing +12%, comfortably above the S&P median. 12 sell-side analysts rate this a Buy with a mean 1-yr target of $980.67 (implying +4% upside).
Moat
FCF converts 134% of net income — earnings translate cleanly into cash. $109.5b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Net margin 1.1% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where HSIC and MCK diverge

On the headline score the gap is 21.5 points in favor of MCK. The widest single difference is Value, where MCK leads by 23.4 points.

Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.

Common questions

Is MCK or HSIC the better stock?

MCK scores higher: MCK 74.2, HSIC 52.7 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.

Where do MCK and HSIC differ most?

The widest gap is value, where MCK leads by 23 points on the 0–100 pillar scale. MCK leads all three pillars, so the gap is broad rather than a single-measure difference.

How are MCK and HSIC scored?

Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.

How current is this comparison?

The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.